Epithalon

Epithalon, also known as Epitalon, is an investigational peptide studied for its potential involvement in cellular and age-related biological pathways. Research involving human use is limited, and its safety, effectiveness, appropriate dosing, and long-term effects have not been established.

This service includes a Good Faith Examination for patients requesting compounded Epithalon peptide therapy. Patients may select a 4-week or 12-week vial; however, the final treatment duration, dosage, and administration schedule are determined by the licensed provider.

The evaluation includes a review of your medical history, current medications, allergies, health goals, and relevant risk factors. Additional medical information or laboratory testing may be requested before the provider determines whether treatment is clinically appropriate.

If treatment is approved, the prescription is prepared by a qualified compounding pharmacy and shipped according to the pharmacy’s procedures. Completing the examination or purchasing this service does not guarantee that Epithalon will be prescribed.

All prescribing decisions are made solely by the licensed provider based on the individual patient evaluation, applicable medical standards, pharmacy requirements, state regulations, and product availability.